MEDNAX (MD) Tops Q4 EPS by 3c

MEDNAX (NYSE: MD) reported Q4 EPS of $1.13, $0.03 better than the analyst estimate of $1.10. Revenue for the quarter came in at $742 million versus the consensus estimate of $747.88 million.

GUIDANCE:

MEDNAX sees Q1 2016 EPS of $0.85-$0.89, versus the consensus of $0.89.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)